Galapagos NV (GLPGF)
OTCMKTS · Delayed Price · Currency is USD
33.45
0.00 (0.00%)
Aug 26, 2025, 8:00 PM EDT
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
$580,062
Profits / Employee
-$598,299
Market Cap
2.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | 1,489 | 486 | 48.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tian'an Technology Group | 8 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 68 |
| CytoDyn | 13 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
Galapagos NV News
- 2 months ago - Galapagos appoints Aaron Cox as CFO - Seeking Alpha
- 2 months ago - Galapagos Appoints Aaron Cox as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101 - GlobeNewsWire
- 2 months ago - Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL - GlobeNewsWire
- 3 months ago - Galapagos Creates New Subscription Right Plan - GlobeNewsWire
- 3 months ago - Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes - GlobeNewsWire
- 4 months ago - Galapagos: Targeting High Unmet Medical Need Of MCL Focus With GLPG5101 - Seeking Alpha
- 4 months ago - Galapagos NV outlines plans for pivotal CAR-T trials and SpinCo separation in 2025 - Seeking Alpha